School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Medical, Molecular and Forensic Sciences, Murdoch University, Perth, WA, Australia.
Clin Microbiol Infect. 2020 Jul;26(7):857-863. doi: 10.1016/j.cmi.2019.10.023. Epub 2019 Nov 1.
For over four decades, Clostridium difficile has been a significant enteric pathogen of humans. It is associated with the use of antimicrobials that generally disrupt the microbiota of the gastrointestinal tract. Previously, it was thought that C. difficile was primarily a hospital-acquired infection; however, with the emergence of community-associated cases, and whole-genome sequencing suggesting the majority of the hospital C. difficile infection (CDI) cases are genetically distinct from one another, there is compelling evidence that sources/reservoirs of C. difficile outside hospitals play a significant role in the transmission of CDI.
To review the 'One Health' aspects of CDI, focusing on how community sources/reservoirs might be acting as a conduit in the transfer of C. difficile between animals and humans. The importance of a One Health approach in managing CDI is discussed.
A literature search was performed on PubMed and Web of Science for relevant papers published from 1 January 2000 to 10 July 2019.
We present evidence that demonstrates transmission of C. difficile in hospitals from asymptomatic carriers to symptomatic CDI patients. The source of colonization is most probably community reservoirs, such as foods and the environment, where toxigenic C. difficile strains have frequently been isolated. With high-resolution genomic sequencing, the transmission of C. difficile between animals and humans can be demonstrated, despite a clear epidemiological link often being absent. The ways in which C. difficile from animals and humans can disseminate through foods and the environment are discussed, and an interconnected transmission pathway for C. difficile involving food animals, humans and the environment is presented.
Clostridium difficile is a well-established pathogen of both humans and animals that contaminates foods and the environment. To manage CDI, a One Health approach with the collaboration of clinicians, veterinarians, environmentalists and policy-makers is paramount.
四十多年来,艰难梭菌一直是人类重要的肠道病原体。它与通常破坏胃肠道微生物群的抗生素的使用有关。以前,人们认为艰难梭菌主要是医院获得性感染;然而,随着社区相关性病例的出现,以及全基因组测序表明大多数医院艰难梭菌感染(CDI)病例彼此之间在基因上存在差异,有确凿的证据表明,医院外的艰难梭菌来源/储存库在 CDI 的传播中发挥了重要作用。
综述 CDI 的“同一健康”方面,重点讨论社区来源/储存库如何在艰难梭菌在动物和人类之间的转移中充当媒介。讨论了采用同一健康方法管理 CDI 的重要性。
在 PubMed 和 Web of Science 上进行了文献检索,检索了 2000 年 1 月 1 日至 2019 年 7 月 10 日期间发表的相关论文。
我们提供的证据表明,在医院中,无症状携带者会将艰难梭菌传播给有症状的 CDI 患者。定植的来源很可能是社区储存库,例如食物和环境,那里经常分离出产毒艰难梭菌菌株。通过高分辨率基因组测序,可以证明艰难梭菌在动物和人类之间传播,尽管通常不存在明确的流行病学联系。讨论了动物和人类的艰难梭菌如何通过食物和环境传播的方式,并提出了一个涉及食源性动物、人类和环境的艰难梭菌相互关联的传播途径。
艰难梭菌是人类和动物的一种既定病原体,可污染食物和环境。为了管理 CDI,临床医生、兽医、环保主义者和政策制定者合作的同一健康方法至关重要。